{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:14:15Z","timestamp":1778688855392,"version":"3.51.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,20]]},"DOI":"10.1097\/qad.0b013e32835d0da1","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T15:15:28Z","timestamp":1356016528000},"page":"529-538","source":"Crossref","is-referenced-by-count":27,"title":["Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy"],"prefix":"10.1097","volume":"27","author":[{"given":"Lander","family":"Ega\u00f1a-Gorro\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bru","family":"Cormand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuixent","family":"Escrib\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Gatell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Arnedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","article-title":"Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R2-4-20210130","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/14656566.6.10.1619","article-title":"Treatment of dyslipidaemia in HIV-infected persons.","volume":"6","author":"Manuel","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-9343(93)90087-6","article-title":"Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection.","volume":"94","author":"Shor-Posner","year":"1993","journal-title":"Am J Med"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","article-title":"Hypertriglyceridemia in the acquired immunodeficiency syndrome.","volume":"86","author":"Grunfeld","year":"1989","journal-title":"Am J Med"},{"key":"R5-4-20210130","first-page":"1045","article-title":"Lipids lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-4-20210130","first-page":"112","article-title":"Dyslipidemia and its treatment in HIV infection.","volume":"18","author":"Grunfeld","year":"2010","journal-title":"Top HIV Med"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00002030-200102160-00005","article-title":"Premature atherosclerosis in HIV-infected individuals: focus on protease inhibitor therapy.","volume":"15","author":"Depairon","year":"2001","journal-title":"AIDS"},{"key":"R8-4-20210130","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction.","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients: association with antiretroviral therapy. Results from the DAD study.","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"R10-4-20210130","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction.","volume":"356","author":"Group","year":"2007","journal-title":"N Engl J Med"},{"key":"R11-4-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/429295","article-title":"Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.","volume":"191","author":"Tarr","year":"2005","journal-title":"J Infect Dis"},{"key":"R12-4-20210130","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/FPC.0b013e32814db8b7","article-title":"Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.","volume":"17","author":"Arnedo","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCGENETICS.109.874412","article-title":"Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.","volume":"2","author":"Rotger","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1756-0500-3-39","article-title":"Interpretation of custom designed Illumina genotype cluster plots for targeted association studies and next-generation sequence validation.","volume":"3","author":"Tindall","year":"2010","journal-title":"BMC Res Notes"},{"key":"R15-4-20210130","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9. low LDL. and protection against coronary heart disease.","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"R16-4-20210130","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/01.ATV.14.7.1066","article-title":"Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia.","volume":"14","author":"Hoeg","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"R17-4-20210130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/COH.0b013e3282fb7bb9","article-title":"Effectiveness of lipid-lowering therapy in HIV patients.","volume":"3","author":"Martinez","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"key":"R18-4-20210130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/527564","article-title":"High prevalence of peripheral arterial disease in HIV-infected persons.","volume":"46","author":"Periard","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R19-4-20210130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses.","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R21-4-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps.","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"R22-4-20210130","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data.","volume":"68","author":"Stephens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R23-4-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1479-7364-1-1-63","article-title":"A survey of current software for linkage analysis.","volume":"1","author":"Dudbridge","year":"2003","journal-title":"Hum Genomics"},{"key":"R24-4-20210130","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/321201","article-title":"Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects.","volume":"67","author":"Schork","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R25-4-20210130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.269","article-title":"Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.","volume":"41","author":"Aulchenko","year":"2009","journal-title":"Nat Genet"},{"key":"R26-4-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng.271","article-title":"Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.","volume":"41","author":"Sabatti","year":"2009","journal-title":"Nat Genet"},{"key":"R27-4-20210130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia.","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat Genet"},{"key":"R28-4-20210130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological. clinical and population relevance of 95 loci for blood lipids.","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"R29-4-20210130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1157\/13116658","article-title":"Cardiovascular risk factors. Insights from Framingham Heart Study.","volume":"61","author":"ODonnell","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"R30-4-20210130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1468-1293.2010.00897.x","article-title":"Ontario HIVTNCSTHIVhepatitis C virus and HIVhepatitis B virus coinfections protect against antiretroviral-related hyperlipidaemia.","volume":"12","author":"Diong","year":"2011","journal-title":"HIV Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e32835d0da1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:34:47Z","timestamp":1620956087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201302200-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,20]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32835d0da1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717980148.793473331","asserted-by":"object"}]},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,20]]}}}